N. Kokudo, N. Takemura, K. Hasegawa, T. Takayama, S. Kubo, M. Shimada, H. Nagano, E. Hatano, N. Izumi, S. Kaneko, M. Kudo, H. Iijima, Takuya Genda, R. Tateishi, T. Torimura, H. Igaki, Satoshi Kobayashi, Hideyuki Sakurai, T. Murakami, T. Watadani, Y. Matsuyama
2019.9.6HEPATOLOGY RESEARCH
tlooto Summary
The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development, and Evaluation system, which was published in October 2017 in Japanese.
Abstract
The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence‐based medicine and partly to the Grading of Recommendations Assessment, Development, and Evaluation system, which was published in October 2017 in Japanese. New or revised recommendations were described, herein, with a special reference to the surveillance, diagnostic, and treatment algorithms.
Citation format
KOKUDO, N., et al. Clinical practice guidelines for hepatocellular carcinoma: The Japan society of hepatology 2017 (4th JSH‐HCC guidelines) 2019 update. HEPATOLOGY RESEARCH, 2019, 49: 1109–1113.